Tumor-Targeting Peptides for Therapeutic Gene Delivery (97breast)
Abstract
It is well known that angiogenesis, the recruitment of new blood vessels, is an important rate limiting step in solid tumor growth. New anti-tumor therapies based on the premise that inhibiting angiogenesis suppresses tumor growth are currently being tested in multiple clinical trials (1, 2, 3). Angiogenesis is a multi-stage process that involves the release and activation of angiogenic factors, endothelial cell migration and proliferation, and differentiation into newly formed capillaries.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 1999
- Accession Number
- ADA385450
Entities
People
- Renata Pasquanlini
Organizations
- Sanford Burnham Prebys Medical Discovery Institute